Literature DB >> 18493107

Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: the Persian Gulf Healthy Heart Study.

Iraj Nabipour1, Katayoun Vahdat, Seyed Mojtaba Jafari, Saeideh Beigi, Majid Assadi, Fatemeh Azizi, Zahra Sanjdideh.   

Abstract

Previous studies have suggested that low-grade systemic inflammation is involved in the pathogenesis of type 2 diabetes mellitus. However, limited information is available about the relationship of diabetes mellitus and inflammation in Asia. We examined the association between high-sensitivity C-reactive protein (CRP) levels and diabetes in a general Iranian population. In an ancillary study to the Persian Gulf Healthy Heart Study, a cohort study of men and women aged > or = 25 years, a random sample of 1754 (49.2 percent males, 50.8 percent females) subjects were evaluated. High sensitivity C-reactive protein was measured by enzyme-linked immunosorbent assay. Elevated serum CRP was defined as more than 3.0 mg/l. The diabetes classification was based on the criteria of the American Diabetes Association. A total of 8.6 percent of the subjects (8.0 percent of males &amp; 9.1 percent of females; p>0.05) had type 2 diabetes mellitus. Geometric mean of CRP was 1.94 mg/l (3.80 SD) in the studied population. The subjects with diabetes had a higher geometric mean of CRP levels than the subjects with no diabetes [3.67 (SD 3.71) versus 1.85 (3.83) respectively; p<0.0001)]. In multiple logistic regression analysis, diabetes showed a significant age-adjusted association with elevated CRP levels [Odds Ratio = 2.03, Confidence Interval (1.38-2.98); p<0.0001] after adjusting for sex, LDL-cholesterol, HDL-cholesterol blood pressure, smoking and body mass index. In conclusion, beyond traditional cardiovascular risk factors, elevated CRP is significantly correlated with diabetes in general population of the northern Persian Gulf. Further insight into the specific effects of proinflammatory cytokines and acute-phase proteins will be essential for the development of new preventive strategies for diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493107     DOI: 10.1507/endocrj.k08e-026

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

1.  Chronic inflammation is correlated with percentage of body fat independent of the burden of infection.

Authors:  Katayoun Vahdat; Fatemeh Azizi; Keivan Zandi; Majid Assadi; Iraj Nabipour
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Association between C-reactive protein and type 2 diabetes in a Tunisian population.

Authors:  Hanen Belfki; Samir Ben Ali; Souha Bougatef; Decy Ben Ahmed; Najet Haddad; Awatef Jmal; Monia Abdennebi; Habiba Ben Romdhane
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

3.  Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.

Authors:  Zhen Wang; Hong Zhang; Xu-Hui Shen; Kui-Li Jin; Guo-Fen Ye; Wei Qiu; Li Qian; Bo Li; Yong-Hong Zhang; Guo-Ping Shi
Journal:  Ann Med       Date:  2012-10-30       Impact factor: 4.709

4.  Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c: a study in Indonesia.

Authors:  Hendri Susanto; Willem Nesse; Pieter U Dijkstra; Evelien Hoedemaker; Yvonne Huijser van Reenen; Dewi Agustina; Arjan Vissink; Frank Abbas
Journal:  Clin Oral Investig       Date:  2011-10-20       Impact factor: 3.573

5.  Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus.

Authors:  Majid Khazaei
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

6.  C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese.

Authors:  Angelo C Dongway; Areeg S Faggad; Hani Y Zaki; Badreldin E Abdalla
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-04       Impact factor: 3.168

Review 7.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

8.  High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS).

Authors:  Pooya Koosha; Hamidreza Roohafza; Nizal Sarrafzadegan; Mehrbod Vakhshoori; Mohammad Talaei; Erfan Sheikhbahaei; Masoumeh Sadeghi
Journal:  Glob Heart       Date:  2020-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.